{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:45:58Z","timestamp":1770453958180,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,13]]},"DOI":"10.7759\/cureus.90044","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:58:33Z","timestamp":1755154713000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Euglycemic Diabetic Ketoacidosis: SGLT2 Inhibitor Complication Triggering Acute Coronary Syndrome and Cardiac Arrest Post Coronary Artery Bypass Grafting (CABG)"],"prefix":"10.7759","author":[{"given":"Freideriki","family":"Nteka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippos","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Ballas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4496","article-title":"Post-surgical euglycemic diabetic ketoacidosis in a patient on empagliflozin in the intensive care unit","volume":"11","author":"Bteich F","year":"2019","unstructured":"Bteich F, Daher G, Kapoor A, Charbek E, Kamel G. Post-surgical euglycemic diabetic ketoacidosis in a patient on empagliflozin in the intensive care unit. Cureus. 2019, 11:e4496. 10.7759\/cureus.4496","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review","volume":"123","author":"Thiruvenkatarajan V","year":"2019","unstructured":"Thiruvenkatarajan V, Meyer EJ, Nanjappa N, Van Wijk RM, Jesudason D. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019, 123:27-36. 10.1016\/j.bja.2019.03.028","journal-title":"Br J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247921","article-title":"Euglycaemic diabetic ketoacidosis in a patient with pancreatitis and type 2 diabetes on empagliflozin","volume":"15","author":"Bardhi O","year":"2022","unstructured":"Bardhi O, Bloom MD, Sattari M. Euglycaemic diabetic ketoacidosis in a patient with pancreatitis and type 2 diabetes on empagliflozin. BMJ Case Rep. 2022, 15:e247921. 10.1136\/bcr-2021-247921","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24016","article-title":"An unsuspected case of euglycemic diabetic ketoacidosis with twists","volume":"14","author":"Kang CY","year":"2022","unstructured":"Kang CY, Khamooshi P, Reyes Pinzon V. An unsuspected case of euglycemic diabetic ketoacidosis with twists. Cureus. 2022, 14:e24016. 10.7759\/cureus.24016","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7074868","article-title":"Newer perspectives of mechanisms for euglycemic diabetic ketoacidosis","volume":"2018","author":"Yu X","year":"2018","unstructured":"Yu X, Zhang S, Zhang L. Newer perspectives of mechanisms for euglycemic diabetic ketoacidosis. Int J Endocrinol. 2018, 2018:7074868. 10.1155\/2018\/7074868","journal-title":"Int J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14070665","article-title":"From sweet to sour: SGLT-2-inhibitor-induced euglycemic diabetic ketoacidosis","volume":"14","author":"Koceva A","year":"2024","unstructured":"Koceva A, Kravos Tram\u0161ek NA. From sweet to sour: SGLT-2-inhibitor-induced euglycemic diabetic ketoacidosis. J Pers Med. 2024, 14:665. 10.3390\/jpm14070665","journal-title":"J Pers Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2021.266","article-title":"Euglycemic diabetic ketoacidosis (EDKA) in a patient receiving dapagliflozin","volume":"17","author":"Sethi SM","year":"2021","unstructured":"Sethi SM, Vohra M, Ali SA. Euglycemic diabetic ketoacidosis (EDKA) in a patient receiving dapagliflozin. Acta Endocrinol (Buchar). 2021, 17:266-9. 10.4183\/aeb.2021.266","journal-title":"Acta Endocrinol (Buchar)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6089","article-title":"Dapagliflozin-induced late-onset euglycemic diabetic ketoacidosis","volume":"11","author":"Iqbal I","year":"2019","unstructured":"Iqbal I, Hamid M, Khan MA, Kainat A, Tariq S. Dapagliflozin-induced late-onset euglycemic diabetic ketoacidosis. Cureus. 2019, 11:e6089. 10.7759\/cureus.6089","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2086520","article-title":"Euglycemic diabetic ketoacidosis in a sedated patient after coronary artery bypass grafting: a case report and literature review","volume":"2021","author":"Alabdaljabar MS","year":"2021","unstructured":"Alabdaljabar MS, Abdullah KM, Almasood A, Ali SS, Ashmeg A. Euglycemic diabetic ketoacidosis in a sedated patient after coronary artery bypass grafting: a case report and literature review. Case Rep Med. 2021, 2021:2086520. 10.1155\/2021\/2086520","journal-title":"Case Rep Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003666","article-title":"Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors","volume":"11","author":"Chow E","year":"2023","unstructured":"Chow E, Clement S, Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2023, 11:e003666. 10.1136\/bmjdrc-2023-003666","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.12968\/hmed.2024.0611","article-title":"Management of SGLT-2 inhibitors in the perioperative period: withhold or continue?","volume":"86","author":"Pittack Z","year":"2025","unstructured":"Pittack Z. Management of SGLT-2 inhibitors in the perioperative period: withhold or continue?. Br J Hosp Med. 2025, 86:1-4.","journal-title":"Br J Hosp Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13665","article-title":"Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter-2 inhibitors: a focused review of pathophysiology, risk factors, and triggers","volume":"13","author":"Somagutta MR","year":"2021","unstructured":"Somagutta MR, Agadi K, Hange N, et al.. Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter-2 inhibitors: a focused review of pathophysiology, risk factors, and triggers. Cureus. 2021, 13:e13665. 10.7759\/cureus.13665","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034027","article-title":"Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes","volume":"102","author":"Alduraibi RK","year":"2023","unstructured":"Alduraibi RK, Alrebdi YM, Altowayan YF. Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes. Medicine (Baltimore). 2023, 102:e34027. 10.1097\/MD.0000000000034027","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0003134820956352","article-title":"Euglycemic diabetic ketoacidosis in the surgical patient","volume":"89","author":"McCabe DE","year":"2023","unstructured":"McCabe DE, Strollo BP, Fuhrman GM. Euglycemic diabetic ketoacidosis in the surgical patient. Am Surg. 2023, 89:1083-6. 10.1177\/0003134820956352","journal-title":"Am Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396216-a-case-of-euglycemic-diabetic-ketoacidosis-sglt2-inhibitor-complication-triggering-acute-coronary-syndrome-and-cardiac-arrest-post-coronary-artery-bypass-grafting-cabg","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:58:33Z","timestamp":1755154713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396216-a-case-of-euglycemic-diabetic-ketoacidosis-sglt2-inhibitor-complication-triggering-acute-coronary-syndrome-and-cardiac-arrest-post-coronary-artery-bypass-grafting-cabg"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.90044","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}